International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): Clinical implications and treatment practice suggestions
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abidin, 1990
Abikoff, 1988, Cognitive training in academically deficient ADHD boys receiving stimulant medication, J. Abnorm. Child Psychol., 16, 411, 10.1007/BF00914172
Achenbach, 2001
Aleman, 2001, Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials, Eur. Neuropsychopharmacol., 11, 289, 10.1016/S0924-977X(01)00097-9
Aman, 2002, Group T.R.D.B.S. Risperidone Treatment of Children With Disruptive Behavior Symptoms and Subaverage IQ: A Double-Blind Placebo-Controlled Study, Am. J. Psychiatry, 159, 1337, 10.1176/appi.ajp.159.8.1337
Aman, 1996, The Nisonger CBRF: a child behavior rating form for children with developmental disabilities, Res. Dev. Disabil., 17, 41, 10.1016/0891-4222(95)00039-9
Aman, M.G., Lindsay, R.L., 2003. Psychotropic Medicines and Aggressive Behavior. Part I: Psychostimulants. Child Adolescent Psychiatry Newslett., in press.
Angold, 2000, The Child and Adolescent Psychiatric Assessment, J. Am. Acad. Child Adolesc. Psychiatry, 39, 39, 10.1097/00004583-200001000-00015
1994
Arnold, 2000, Methylphenidate vs. amphetamine: comparative review, J. Attention Disord., 3, 200, 10.1177/108705470000300403
August, 1983, A four-year follow-up of hyperactive boys with and without conduct disorder, Br. J. Psychiatry, 143, 192, 10.1192/bjp.143.2.192
Barkley, 1990
Biederman, 1989, A double-blind placebo controlled study of desipramine in the treatment ADD: II. Serum drug levels and cardiovascular findings, J. Am. Acad. Child Adolesc. Psychiatry, 28, 903, 10.1097/00004583-198911000-00015
Biederman, 1990, Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder, J. Am. Acad. Child Adolesc. Psychiatry, 29, 526, 10.1097/00004583-199007000-00004
Biederman, 1999, Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder, Pediatrics, 104, e20, 10.1542/peds.104.2.e20
Bloomquist, 1997, Social problem solving in hyperactive-aggressive children: how and what they think in conditions of automatic and controlled processing, J. Clin. Child Psychol., 26, 172, 10.1207/s15374424jccp2602_5
Borduin, 1995, Multisystemic treatment of serious juvenile offenders: long-term prevention of criminality and violence, J. Consult Clin. Psychol., 63, 569, 10.1037/0022-006X.63.4.569
Boyle, 1993, Evaluation of the revised Ontario Child Health Study scales, J. Child Psychol. Psychiatry, 34, 189, 10.1111/j.1469-7610.1993.tb00979.x
Buitelaar, 2002, Epidemiology: what have we learned over the last decade
Campbell, 1995, Lithium in hospitalized aggressive children with conduct disorder: a double-blind and placebo-controlled study, J. Am. Acad. Child Adolesc. Psychiatry, 34, 445, 10.1097/00004583-199504000-00011
Campbell, 1982, Drugs in aggressive behavior, J. Am. Acad. Child Psychiatry, 21, 107, 10.1016/S0002-7138(09)60909-2
Campbell, 1984, Behavioral efficacy of haloperidol and lithium carbonate, Arch. Gen. Psychiatry, 41, 650, 10.1001/archpsyc.1984.01790180020002
Cantwell, 1975, Genetics of hyperactivity, J. Child Psychol. Psychiatry, 16, 261, 10.1111/j.1469-7610.1975.tb01275.x
Carlson, 1992, Single and combined effects of methylphenidate and behavior therapy on the classroom performance of children with attention-deficit hyperactivity disorder, J. Abnorm. Child Psychol., 20, 213, 10.1007/BF00916549
Cohen, 1993, An epidemiological study of disorders in late childhood and adolescence: Age- and gender-specific prevalence, J. Child Psychol. Psychiatry, 34, 851, 10.1111/j.1469-7610.1993.tb01094.x
Conners, 1997
Conners, 1997
Conners, 1973, Rating scales for use in drug studies with children, Psychopharmacol. Bull., 14, 24
Conners, 1996, Bupropion hydrochloride in attention deficit disorder with hyperactivity, J. Am. Acad. Child Adolesc. Psychiatry, 35, 1314, 10.1097/00004583-199610000-00018
Cueva, 1996, Carbamazepine in aggressive children with conduct disorder: A double-blind and placebo-controlled study, J. Am. Acad. Child Adolesc. Psychiatry, 35, 480, 10.1097/00004583-199604000-00014
Cunningham, 1991, A dose–response analysis of the effects of methylphenidate on the peer interactions and simulated classroom performance of ADHD children with and without conduct problems, J. Child Psychol. Psychiatry, 32, 439, 10.1111/j.1469-7610.1991.tb00322.x
Faraone, 1992, Segregation analysis of attention deficit hyperactivity disorder, Psychiatr. Genet., 2, 257, 10.1097/00041444-199210000-00004
Farrington, 1990, Long-term criminal outcomes of hyperactivity-impulsivity-attention deficit and conduct problems in childhood, 62
Findling, 2002, Normalization of prolactin levels in children after long-term treatment with risperidone, Int. J. Neuropsychop., 5, S160
Findling, 2002, Risperidone in children with conduct problems and subaverage IQ, Eur. Psychiatry, 17, 118, 10.1016/S0924-9338(02)80524-7
Findling, 2002, Risperidone in children with disruptive behaviors and subaverage IQ, Eur. Psychiatry, 17, 118, 10.1016/S0924-9338(02)80525-9
Findling, 2000, A double-blind pilot study of risperidone in the treatment of conduct disorder, J. Am. Acad. Child Adolesc. Psychiatry, 39, 509, 10.1097/00004583-200004000-00021
Frick, 1991, History of childhood behavior problems in biological relatives of boys with attention-deficit hyperactivity disorder and conduct disorder, J. Clin. Child Psychol., 20, 445, 10.1207/s15374424jccp2004_14
Gaub, 1997, Gender differences in ADHD: A meta-analysis and critical review, J. Am. Acad. Child Adolesc. Psychiatry, 36, 1036, 10.1097/00004583-199708000-00011
Giedd, 2001, Brain imaging of attention deficit/hyperactivity disorder, Ann. N.Y. Acad. Sci., 931, 33, 10.1111/j.1749-6632.2001.tb05772.x
Gilger, 1992, A twin study of the etiology of comorbidity: Attention-deficit hyperactivity disorder and dyslexia, J. Am. Acad. Child Adolesc. Psychiatry, 31, 343, 10.1097/00004583-199203000-00024
Greenhill, 1985, Molindone hydrochloride treatment of hospitalized children with conduct disorder, J. Clin. Psychiatry, 46, 20
Henggeler, 1986, Multisystemic treatment of juvenile offenders: Effects on adolescent behavior and family interaction, Dev. Psychol., 22, 132, 10.1037/0012-1649.22.1.132
Hinshaw, 1989, Aggressive, prosocial, and nonsocial behavior in hyperactive boys: Dose effects of methylphenidate in naturalistic settings, J. Consult. Clin. Psychol., 57, 636, 10.1037/0022-006X.57.5.636
Hinshaw, 1998, Childhood attention deficit hyperactivity disorder: Nonpharmacological and combination treatments, 24
Jadad, 1998
Kaufman, 1997, Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data, J. Am. Acad. Child Adolesc. Psychiatry, 36, 980, 10.1097/00004583-199707000-00021
Kazdin, 1997, Parent management training: evidence, outcomes, and issues, J. Am. Acad. Child Adolesc. Psychiatry, 36, 1349, 10.1097/00004583-199710000-00016
Kazdin, 1997, Practitioner review: psychosocial treatments for conduct disorder in children, J. Child Psychol. Psychiatry, 38, 161, 10.1111/j.1469-7610.1997.tb01851.x
Kazdin, 2000, Treatments for aggressive and antisocial children, Child Adolesc. Psychiatr. Clin. North Am., 9, 841, 10.1016/S1056-4993(18)30095-6
Keating, 2001, Methylphenidate (OROS formulation), CNS Drugs, 15, 495, 10.2165/00023210-200115060-00006
Kendall, 1990, Cognitive-behavioral treatment of conduct-disordered children, Cognitive Ther. Res., 14, 279, 10.1007/BF01183997
Klein, 1997, Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder, Arch. Gen. Psychiatry, 54, 1073, 10.1001/archpsyc.1997.01830240023003
Kusumakar, 2002, Bipolar mood disorder: diagnosis, etiology and treatment, 106
Kusumakar, 2002, Bipolar disorder in young people, the elderly and pregnant women, 84
Kutcher, 2000, Adolescent onset bipolar illness, 139
Kutcher, S., 1997. Child and Adolescent Psychopharmacology. WB Saunders Company, Philadelphia, pp. 273–294.
Lahey, 1994, Framework for a developmental model of oppositional defiant disorder and conduct disorder, 139
Lahey, 1995, Four-year longitudinal study of conduct disorder in boys: Patterns and predictors of persistence, J. Abnorm. Psychol., 104, 83, 10.1037/0021-843X.104.1.83
Lahey, 1992, Oppositional defiant and conduct disorders: Issues to be resolved for DSM-IV, J. Am. Acad. Child Adolesc. Psychiatry, 31, 539, 10.1097/00004583-199205000-00023
Lambert, 1998, Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants, J. Learn. Disabil., 31, 533, 10.1177/002221949803100603
Lochman, 1992, Cognitive-behavioral intervention with aggressive boys: Three-year follow-up and preventive effects, J. Consult Clin. Psychol., 60, 426, 10.1037/0022-006X.60.3.426
Loeber, 2000, Oppositional defiant and conduct disorder: a review of the past 10 years, part I, J. Am. Acad. Child Adolesc. Psychiatry, 39, 1468, 10.1097/00004583-200012000-00007
Loney, 1982, Hyperactivity, inattention and aggression in clinical practice, 113
Malone, 1998, Aggression classification and treatment response, Psychopharmacol. Bull., 34, 41
Malone, 2000, A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder, Arch. Gen. Psychiatry, 57, 649, 10.1001/archpsyc.57.7.649
Mannuzza, 1993, Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status, Arch. Gen. Psychiatry, 50, 565, 10.1001/archpsyc.1993.01820190067007
McDermott, 1996, A nationwide study of developmental and gender prevalence for psychopathology in childhood and adolescence, J. Abnorm. Child Psychol., 24, 53, 10.1007/BF01448373
McGee, 1990, DSM-III disorders in a large sample of adolescents, J. Am. Acad. Child Adolesc. Psychiatry, 29, 611, 10.1097/00004583-199007000-00016
Michelson, 2001, Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose–response study, Pediatrics, 108, E83, 10.1542/peds.108.5.e83
Modi, 2000, Single- and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS (methylphenidate HCl) formulation, J. Clin. Pharmacol., 40, 379, 10.1177/00912700022009080
Morrison, 1973, The psychiatric status of the legal families of adopted hyperactive children, Arch. Gen. Psychiatry, 28, 888, 10.1001/archpsyc.1973.01750360098015
Nadder, 1998, Genetic effects on ADHD symptomatology in 7- to 13-year-old twins: results from a telephone survey, Behav. Genet., 28, 83, 10.1023/A:1021686906396
NICE, 2000. Guidance on the use of methylphenidate for attention deficit/hyperactivity disorder (ADHD) in Childhood Technology Appraisal Guidance No. 13. In: Technology Appraisal Guidance No. 13. London: NICE.
Offord, 1987, Ontario Child Health Study. II. Six-month prevalence of disorder and rates of service utilization, Arch. Gen. Psychiatry, 44, 832, 10.1001/archpsyc.1987.01800210084013
Pauls, 1983, Demonstration of vertical transmission of attention deficit disorder, Ann. Neurol., 14, 363
Pelham, 1993, Separate and combined effects of methylphenidate and behavior modification on boys with attention deficit-hyperactivity disorder in the classroom, J. Consult Clin. Psychol., 61, 506, 10.1037/0022-006X.61.3.506
Pelham, 1992, Teacher ratings of DSM-III-R symptoms for the disruptive behavior disorders, J. Am. Acad. Child Adolesc. Psychiatry, 31, 210, 10.1097/00004583-199203000-00006
Pelham, 1998, Empirically supported psychosocial treatments for attention deficit hyperactivity disorder, J. Clin. Child Psychol., 27, 190, 10.1207/s15374424jccp2702_6
Pine, 2001, Mapping brain circuits in developmental psychopathology: ADHD and anxiety as examples, 335
Pliszka, 1987, Tricyclic antidepressants in the treatment of children with attention deficit disorder, J. Am. Acad. Child Adolesc. Psychiatry, 26, 127, 10.1097/00004583-198703000-00002
Popper, 1988, Disorders usually first evident in infancy, childhood, or adolescence, 649
Raine, 2000, Reduced prefrontal gray matter volume and reduced autonomic activity in antisocial personality disorder, Arch. Gen. Psychiatry, 57, 119, 10.1001/archpsyc.57.2.119
Reeves, 1987, Attention deficit, conduct, oppositional, and anxiety disorders in children: II Clinical characteristics, J. Am. Acad. Child Adolesc. Psychiatry, 26, 144, 10.1097/00004583-198703000-00004
Reich, 2000, Diagnostic interview for children and adolescents (DICA), J. Am. Acad. Child Adolesc. Psychiatry, 39, 59, 10.1097/00004583-200001000-00017
Ross, 1982
Rutter, 1998
Rutter, 1997, Heterogeneity of antisocial behavior: Causes, continuities, and consequences, Nebr. Symp. Motiv., 44, 45
Schachar, 1981, The characteristics of situationally and pervasively hyperactive children: Implications for syndrome definition, J. Child Psychol. Psychiatry, 22, 375, 10.1111/j.1469-7610.1981.tb00562.x
Schachar, 1990, Hyperactivity and parental psychopathology, J. Child Psychol. Psychiatry, 31, 381, 10.1111/j.1469-7610.1990.tb01576.x
Scott, 2001, Financial cost of social exclusion: Follow up study of antisocial children into adulthood, Br. Med. J., 323, 191, 10.1136/bmj.323.7306.191
Shaffer, 2000, NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): Description, differences from previous versions, and reliability of some common diagnoses, J. Am. Acad. Child Adolesc. Psychiatry, 39, 28, 10.1097/00004583-200001000-00014
Sherman, 1997, Attention-deficit hyperactivity disorder dimensions: A twin study of inattention and impulsivity-hyperactivity, J. Am. Acad. Child Adolesc. Psychiatry, 36, 745, 10.1097/00004583-199706000-00010
Spencer, 1996, Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle, J Am Acad Child Adolesc Psychiatry, 35, 409, 10.1097/00004583-199604000-00008
Swanson, 1995
Swanson, 1998, Evaluation of individual subjects in the analog classroom setting: I Examples of graphical and statistical procedures for within-subject ranking of responses to different delivery patterns of methylphenidate, Psychopharmacol. Bull., 34, 825
Szatmari, 1989, ADHD and conduct disorder: degree of diagnostic overlap and differences among correlates, J. Am. Acad. Child Adolesc. Psychiatry, 28, 865, 10.1097/00004583-198911000-00010
Tasse, 1996, The Nisonger Child Behavior Rating Form: age and gender effects and norms, Res. Dev. Disabil., 17, 59, 10.1016/0891-4222(95)00037-2
Taylor, 1994, Syndromes of attention deficit and overactivity, 284
Taylor, 1996, Hyperactivity and conduct problems as risk factors for adolescent development, J. Am. Acad. Child Adolesc. Psychiatry, 35, 1213, 10.1097/00004583-199609000-00019
Taylor, 1987, Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour, Psychol. Med., 17, 121, 10.1017/S0033291700013039
Thapar, 2001, Examining the comorbidity of ADHD-related behaviours and conduct problems using a twin study design, Br. J. Psychiatry, 179, 224, 10.1192/bjp.179.3.224
1999, A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder, Arch. Gen. Psychiatry, 56, 1073, 10.1001/archpsyc.56.12.1073
Turgay, 2002, Risperidone in children with subaverage IQ and behavior disorders, Eur. Psychiatry, 17, 118, 10.1016/S0924-9338(02)80523-5
Vaidya, 1998, Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study, Proc. Natl. Acad. Sci. USA, 95, 14494, 10.1073/pnas.95.24.14494
Vitiello, 1990, Subtyping aggression in children and adolescents, J. Neuropsychiatry Clin. Neurosci., 2, 189, 10.1176/jnp.2.2.189
Weinshenker, 2002, Bimodal classification of aggression: Affective defense and predatory attack, Aggress. Violent Behav., 7, 237, 10.1016/S1359-1789(01)00042-8
Weiss, 1985, Psychiatric status of hyperactives as adults: A controlled prospective 15-year follow-up of 63 hyperactive children, J. Am. Acad. Child Psychiatry, 24, 211, 10.1016/S0002-7138(09)60450-7
Weiss, 1993
1993
2001
Wigal, 1998, Reliability and validity of the SKAMP rating scale in a laboratory school setting, Psychopharmacol. Bull., 34, 47
Wilens, 2002